Applied Therapeutics (APLT) Free Cash Flow (2023 - 2025)
Historic Free Cash Flow for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to -$18.4 million.
- Applied Therapeutics' Free Cash Flow rose 2112.73% to -$18.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.8 million, marking a year-over-year decrease of 611.67%. This contributed to the annual value of -$84.3 million for FY2024, which is 5280.12% down from last year.
- Latest data reveals that Applied Therapeutics reported Free Cash Flow of -$18.4 million as of Q3 2025, which was up 2112.73% from -$20.3 million recorded in Q2 2025.
- Applied Therapeutics' Free Cash Flow's 5-year high stood at -$7.0 million during Q1 2023, with a 5-year trough of -$28.6 million in Q1 2025.
- Moreover, its 3-year median value for Free Cash Flow was -$18.9 million (2024), whereas its average is -$18.8 million.
- Per our database at Business Quant, Applied Therapeutics' Free Cash Flow plummeted by 17054.36% in 2024 and then surged by 2112.73% in 2025.
- Over the past 3 years, Applied Therapeutics' Free Cash Flow (Quarter) stood at -$17.0 million in 2023, then dropped by 14.49% to -$19.5 million in 2024, then rose by 5.49% to -$18.4 million in 2025.
- Its Free Cash Flow was -$18.4 million in Q3 2025, compared to -$20.3 million in Q2 2025 and -$28.6 million in Q1 2025.